- Home
- MFIN vs TVGN Comparison
MFIN vs TVGN Comparison
Compare MFIN & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFIN
- TVGN
- Stock Information
- Founded
- MFIN 1995
- TVGN 2020
- Country
- MFIN United States
- TVGN United States
- Employees
- MFIN N/A
- TVGN N/A
- Industry
- MFIN Finance: Consumer Services
- TVGN Blank Checks
- Sector
- MFIN Finance
- TVGN Finance
- Exchange
- MFIN Nasdaq
- TVGN Nasdaq
- Market Cap
- MFIN 224.2M
- TVGN 193.1M
- IPO Year
- MFIN 1996
- TVGN N/A
- Fundamental
- Price
- MFIN $9.79
- TVGN $1.24
- Analyst Decision
- MFIN
- TVGN Strong Buy
- Analyst Count
- MFIN 0
- TVGN 1
- Target Price
- MFIN N/A
- TVGN $10.00
- AVG Volume (30 Days)
- MFIN 71.2K
- TVGN 727.8K
- Earning Date
- MFIN 07-29-2025
- TVGN 08-13-2025
- Dividend Yield
- MFIN 4.90%
- TVGN N/A
- EPS Growth
- MFIN N/A
- TVGN N/A
- EPS
- MFIN 1.60
- TVGN N/A
- Revenue
- MFIN $316,751,000.00
- TVGN N/A
- Revenue This Year
- MFIN N/A
- TVGN N/A
- Revenue Next Year
- MFIN $5.24
- TVGN N/A
- P/E Ratio
- MFIN $6.11
- TVGN N/A
- Revenue Growth
- MFIN 13.91
- TVGN N/A
- 52 Week Low
- MFIN $7.21
- TVGN $0.26
- 52 Week High
- MFIN $10.50
- TVGN $3.09
- Technical
- Relative Strength Index (RSI)
- MFIN 58.96
- TVGN 51.33
- Support Level
- MFIN $9.31
- TVGN $1.20
- Resistance Level
- MFIN $10.19
- TVGN $1.27
- Average True Range (ATR)
- MFIN 0.41
- TVGN 0.06
- MACD
- MFIN 0.05
- TVGN -0.00
- Stochastic Oscillator
- MFIN 73.29
- TVGN 55.88
About MFIN Medallion Financial Corp.
Medallion Financial Corp is a finance company that originates and services loans in various industries. The five operating segments are, (1) recreation, (2) home improvement, (3) commercial, (4) taxi medallion, and (5) strategic partnership loans. The company generates maximum revenue from the Recreation segment.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.